This is a U.S. news story, published by vancouversun, that relates primarily to Bobby Shah news.
For more U.S. news, you can click here:
more U.S. newsFor more Bobby Shah news, you can click here:
more Bobby Shah newsFor more drug discoveries news, you can click here:
more drug discoveries newsFor more news from vancouversun, you can click here:
more news from vancouversunOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about
specialized clandestine lab team. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest RCMP news, pharmaceutical imprints news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
clandestine lab teamvancouversun
•65% Informative
Bobby Shah , also known as Bahman Djebelibak , was sanctioned in the U.S. last year for allegedly selling precursor chemicals to organized criminals.
Shah and his Port Coquitlam companies were among 28 companies and individuals sanctioned.
Shah has filed a lawsuit against the B.C. Public Guardian and Trustee alleging the public body was mishandling the estate of his estranged wife.
VR Score
57
Informative language
49
Neutral language
68
Article tone
formal
Language
English
Language complexity
56
Offensive language
possibly offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
short-lived
External references
8
Source diversity
5